Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Afatinib

Afatinib

850140-72-6

DISCOVER
Axitinib

Axitinib

319460-85-0

DISCOVER
Atorvastatin calcium salt

Atorvastatin calcium salt

134523-03-8

DISCOVER
2-(Aminomethyl)-1-ethylpyrrolidine

2-(Aminomethyl)-1-ethylpyrrolidine

26116-12-1

DISCOVER
Adenosine

Adenosine

58-61-7

DISCOVER
4-Acetamido-D3-antipyrine

4-Acetamido-D3-antipyrine

342821-66-3

DISCOVER
Anhydro Erythromycin A

Anhydro Erythromycin A

23893-13-2

DISCOVER
Avanafil

Avanafil

330784-47-9

DISCOVER
Acamprosate Calcium

Acamprosate Calcium

77337-73-6

DISCOVER
4-Aminophenol

4-Aminophenol

123-30-8

DISCOVER
DL-Adrenaline

DL-Adrenaline

329-65-7

DISCOVER
Anisomycin

Anisomycin

22862-76-6

DISCOVER